Frankfurt - Delayed Quote EUR
Cessatech A/S (8GN.F)
1.6640
-0.0380
(-2.23%)
At close: May 16 at 3:29:01 PM GMT+2
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Jes Trygved | Chief Executive Officer | -- | -- | 1973 |
| Mr. Martin Juhl | Chief Scientific Officer and Head of CMC, Device Development & Operations | -- | -- | -- |
| Ms. Louise Bak | Head of Regulatory Affairs | -- | -- | -- |
| Ms. Malene Cording | Head of Clinical Development & Operations | -- | -- | -- |
| Ms. Mai Brigsted Gregersen | Head of Quality Assurance | -- | -- | -- |
Cessatech A/S
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 4
Description
Cessatech A/S, a pharmaceutical company, develops and commercializes medicines for the treatment of pediatric acute pain in Denmark. The company's lead product is CT001, an analgesic nasal spray for the treatment of acute and planned painful procedures in children. It also develops CT002, a nasal spray for sedative procedures for children from 0-17 years of age; and CT003, a local anesthetic gel. The company has a collaboration and license agreement with Ventis Pharma Corporation to develop and formulate pain management therapies. Cessatech A/S was founded in 2020 and is based in Copenhagen, Denmark.
Corporate Governance
Cessatech A/S’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available
Related Tickers
1CVAC.MI CureVac N.V.
3.1860
+4.12%
F6T.DU Fate Therapeutics Inc
0.9210
+0.30%
P0F.F Egetis Therapeutics AB (publ)
0.2740
-7.90%
CSJA.F CSL Limited
68.50
+3.01%
328.SG MeiraGTx Holdings PLC
4.4600
+2.29%
1TB0.SG Orphazyme AS
137.50
0.00%
22UA.MU BioNTech SE
83.10
+0.79%
41X.SG Ardelyx Inc
2.9800
-1.06%
FTD.SG Financière de Tubize SA
121.60
+1.00%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3830
+9.43%